Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.
Upcoming SLAS Events:
SLAS Building Biology in 3D Symposium
SLAS Europe 2024 Conference and Exhibition